South Korea
· Delayed Price · Currency is KRW EASY BIO,Inc. Statistics
Total Valuation
EASY BIO,Inc. has a market cap or net worth of KRW 227.60 billion. The enterprise value is 364.41 billion.
| Market Cap | 227.60B |
| Enterprise Value | 364.41B |
Important Dates
The next estimated earnings date is Friday, March 13, 2026.
| Earnings Date | Mar 13, 2026 |
| Ex-Dividend Date | Mar 9, 2026 |
Share Statistics
EASY BIO,Inc. has 33.08 million shares outstanding. The number of shares has decreased by -2.89% in one year.
| Current Share Class | 33.08M |
| Shares Outstanding | 33.08M |
| Shares Change (YoY) | -2.89% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.37% |
| Owned by Institutions (%) | 0.45% |
| Float | 16.04M |
Valuation Ratios
The trailing PE ratio is 10.35 and the forward PE ratio is 5.98.
| PE Ratio | 10.35 |
| Forward PE | 5.98 |
| PS Ratio | 0.49 |
| PB Ratio | 2.27 |
| P/TBV Ratio | 6.85 |
| P/FCF Ratio | 8.77 |
| P/OCF Ratio | 7.80 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.28, with an EV/FCF ratio of 14.04.
| EV / Earnings | 16.56 |
| EV / Sales | 0.78 |
| EV / EBITDA | 7.28 |
| EV / EBIT | 9.08 |
| EV / FCF | 14.04 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 1.72.
| Current Ratio | 1.48 |
| Quick Ratio | 0.80 |
| Debt / Equity | 1.72 |
| Debt / EBITDA | 3.45 |
| Debt / FCF | 6.65 |
| Interest Coverage | 4.64 |
Financial Efficiency
Return on equity (ROE) is 26.84% and return on invested capital (ROIC) is 13.26%.
| Return on Equity (ROE) | 26.84% |
| Return on Assets (ROA) | 7.80% |
| Return on Invested Capital (ROIC) | 13.26% |
| Return on Capital Employed (ROCE) | 20.40% |
| Weighted Average Cost of Capital (WACC) | 6.56% |
| Revenue Per Employee | 3.52B |
| Profits Per Employee | 166.70M |
| Employee Count | 132 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 7.12 |
Taxes
In the past 12 months, EASY BIO,Inc. has paid 7.48 billion in taxes.
| Income Tax | 7.48B |
| Effective Tax Rate | 24.47% |
Stock Price Statistics
The stock price has increased by +40.27% in the last 52 weeks. The beta is 0.80, so EASY BIO,Inc.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +40.27% |
| 50-Day Moving Average | 6,678.80 |
| 200-Day Moving Average | 5,936.05 |
| Relative Strength Index (RSI) | 44.81 |
| Average Volume (20 Days) | 312,594 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EASY BIO,Inc. had revenue of KRW 465.24 billion and earned 22.00 billion in profits. Earnings per share was 664.56.
| Revenue | 465.24B |
| Gross Profit | 107.87B |
| Operating Income | 40.14B |
| Pretax Income | 30.55B |
| Net Income | 22.00B |
| EBITDA | 50.08B |
| EBIT | 40.14B |
| Earnings Per Share (EPS) | 664.56 |
Balance Sheet
The company has 41.36 billion in cash and 172.59 billion in debt, giving a net cash position of -131.22 billion or -3,966.65 per share.
| Cash & Cash Equivalents | 41.36B |
| Total Debt | 172.59B |
| Net Cash | -131.22B |
| Net Cash Per Share | -3,966.65 |
| Equity (Book Value) | 100.16B |
| Book Value Per Share | 2,858.87 |
| Working Capital | 61.46B |
Cash Flow
In the last 12 months, operating cash flow was 29.19 billion and capital expenditures -3.23 billion, giving a free cash flow of 25.96 billion.
| Operating Cash Flow | 29.19B |
| Capital Expenditures | -3.23B |
| Free Cash Flow | 25.96B |
| FCF Per Share | 784.73 |
Margins
Gross margin is 23.19%, with operating and profit margins of 8.63% and 4.73%.
| Gross Margin | 23.19% |
| Operating Margin | 8.63% |
| Pretax Margin | 6.57% |
| Profit Margin | 4.73% |
| EBITDA Margin | 10.76% |
| EBIT Margin | 8.63% |
| FCF Margin | 5.58% |
Dividends & Yields
This stock pays an annual dividend of 250.00, which amounts to a dividend yield of 3.79%.
| Dividend Per Share | 250.00 |
| Dividend Yield | 3.79% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 30.39% |
| Buyback Yield | 2.89% |
| Shareholder Yield | 6.42% |
| Earnings Yield | 9.67% |
| FCF Yield | 11.41% |
Stock Splits
The last stock split was on December 21, 2020. It was a forward split with a ratio of 5.
| Last Split Date | Dec 21, 2020 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
EASY BIO,Inc. has an Altman Z-Score of 2.79 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.79 |
| Piotroski F-Score | 6 |